- Home
- ADSE vs VSTM Comparison
ADSE vs VSTM Comparison
Compare ADSE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- VSTM
- Stock Information
- Founded
- ADSE 1980
- VSTM 2010
- Country
- ADSE Ireland
- VSTM United States
- Employees
- ADSE N/A
- VSTM N/A
- Industry
- ADSE Industrial Specialties
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- ADSE Consumer Discretionary
- VSTM Health Care
- Exchange
- ADSE Nasdaq
- VSTM Nasdaq
- Market Cap
- ADSE 647.1M
- VSTM 531.1M
- IPO Year
- ADSE N/A
- VSTM 2012
- Fundamental
- Price
- ADSE $12.98
- VSTM $9.25
- Analyst Decision
- ADSE
- VSTM Strong Buy
- Analyst Count
- ADSE 0
- VSTM 8
- Target Price
- ADSE N/A
- VSTM $12.43
- AVG Volume (30 Days)
- ADSE 52.6K
- VSTM 2.9M
- Earning Date
- ADSE 09-12-2025
- VSTM 08-07-2025
- Dividend Yield
- ADSE N/A
- VSTM N/A
- EPS Growth
- ADSE N/A
- VSTM N/A
- EPS
- ADSE N/A
- VSTM N/A
- Revenue
- ADSE $113,896,884.00
- VSTM $2,137,000.00
- Revenue This Year
- ADSE $219.58
- VSTM $86.06
- Revenue Next Year
- ADSE N/A
- VSTM $395.22
- P/E Ratio
- ADSE N/A
- VSTM N/A
- Revenue Growth
- ADSE 2.45
- VSTM N/A
- 52 Week Low
- ADSE $9.00
- VSTM $2.34
- 52 Week High
- ADSE $16.35
- VSTM $9.43
- Technical
- Relative Strength Index (RSI)
- ADSE 65.03
- VSTM 73.31
- Support Level
- ADSE $11.76
- VSTM $8.71
- Resistance Level
- ADSE $12.45
- VSTM $9.43
- Average True Range (ATR)
- ADSE 0.73
- VSTM 0.61
- MACD
- ADSE 0.14
- VSTM 0.08
- Stochastic Oscillator
- ADSE 89.07
- VSTM 90.95
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.